{"id":494419,"date":"2021-05-17T09:39:03","date_gmt":"2021-05-17T13:39:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/"},"modified":"2021-05-17T09:39:03","modified_gmt":"2021-05-17T13:39:03","slug":"alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/","title":{"rendered":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences<\/b><\/p>\n<p><b>Minimally-invasive, implant-free technology for heart failure patients studied at 1 and 3 months<\/b><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alleviantmedical.com%2F&amp;esheet=52430338&amp;newsitemid=20210517005480&amp;lan=en-US&amp;anchor=Alleviant+Medical+Inc.&amp;index=1&amp;md5=1fdd8d579c41187c187b042b6083bc9a\">Alleviant Medical Inc.<\/a>, a privately-held medical device company, today announced one-month and three-month follow up data from the first in human clinical study (ALLEVIATE-HF-1) of its technology for the treatment of heart failure with preserved ejection fraction (HFpEF).\n<\/p>\n<p>\nThe Alleviant System is a novel transcatheter device for the creation of a therapeutic interatrial shunt without a permanent cardiac implant. Results were presented at the American College of Cardiology Scientific Session (ACC.21) and at the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR 2021) by Colin Barker, MD, Director of Interventional Cardiology at Vanderbilt University, Nashville, TN and Jacob Kriegel, MD, Chief Medical Officer of Alleviant Medical.\n<\/p>\n<p>\nThe reported results of this ongoing first in human study include safety and objective clinical and quality of life outcome measures at one and three-months post-procedure in ten subjects. Data highlights include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nConfirmed shunt patency in all subjects at 3 months;\n<\/li>\n<li>\nReduction in mean peak exercise pulmonary capillary wedge pressure (PCWP) by 20% (8 mmHg, p=.026) at 1 month;\n<\/li>\n<li>\nReduction in mean NT-proBNP by 48% (582 pg\/ml, p&lt;.001) at 3 months;\n<\/li>\n<li>\nIncrease in mean 6-minute walk distance by 50% (110 meters, p&lt;.001) at 3 months;\n<\/li>\n<li>\nIncrease in mean Kansas City Cardiomyopathy Questionnaire overall summary score by 87% (23 points, p&lt;.001, consistent with a large clinical improvement) at 3 months;\n<\/li>\n<li>\nNo device-related or procedure-related adverse events through 3 months\n<\/li>\n<\/ul>\n<p>\n\u201cDue to the limited medical or device options to treat heart failure with preserved ejection fraction, providers have few tools for helping patients manage the resulting shortness of breath and reduced quality of life,\u201d commented James Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, an advisor to the company. \u201cWe are encouraged by these early data highlighting outcomes for a no-implant interatrial shunt procedure and look forward to collaborating on further clinical evidence development with the Alleviant technology.\u201d\n<\/p>\n<p>\n\u201cOur focus and mission at Alleviant Medical is to deliver a simple, reproducible no-implant interatrial shunt technology to heart failure patients and healthcare providers,\u201d said Adam Berman, CEO of Alleviant Medical. \u201cWe are very pleased with the investigator-presented data at these two prestigious cardiology conferences and look forward to subsequent data releases from the ongoing clinical studies with our technology over the upcoming months.\u201d\n<\/p>\n<p><b>About Alleviant Medical:<\/b><\/p>\n<p>\nAlleviant Medical is a privately held medical device company that is dedicated to developing novel therapies for patients suffering from heart failure. The company has developed a transcatheter technology intended to decompress the left atrium without a permanent cardiac implant or open surgery. The procedure is designed to be performed under fluoroscopy (x-ray) and ultrasound guidance using a minimally-invasive approach and leverages standard interventional cardiology techniques. The company\u2019s mission is to alleviate the significant clinical and economic burden of heart failure and to improve the lives of millions of patients suffering from this debilitating disease. Alleviant Medical\u2019s investment partners include Vensana Capital, Broadview and Longview Ventures, TMC Venture Fund, S3 Ventures and an undisclosed strategic investor.\n<\/p>\n<p>\nThe Alleviant Medical technology is under investigational use only and not available for commercial distribution in the United States or any other market.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210517005480\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210517005480\/en\/<\/a><\/span><\/p>\n<p>\nMerina Zeller<br \/>\n<br \/>781-913-4480\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Venture Capital Cardiology Biotechnology Surgery Health Medical Devices Professional Services Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210517005480\/en\/878785\/3\/ALLEVIANT_LOGO_%28002%29-%28002%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences Minimally-invasive, implant-free technology for heart failure patients studied at 1 and 3 months AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Alleviant Medical Inc., a privately-held medical device company, today announced one-month and three-month follow up data from the first in human clinical study (ALLEVIATE-HF-1) of its technology for the treatment of heart failure with preserved ejection fraction (HFpEF). The Alleviant System is a novel transcatheter device for the creation of a therapeutic interatrial shunt without a permanent cardiac implant. Results were presented at the American College of Cardiology Scientific Session (ACC.21) and at the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR 2021) by Colin Barker, MD, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-494419","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences Minimally-invasive, implant-free technology for heart failure patients studied at 1 and 3 months AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Alleviant Medical Inc., a privately-held medical device company, today announced one-month and three-month follow up data from the first in human clinical study (ALLEVIATE-HF-1) of its technology for the treatment of heart failure with preserved ejection fraction (HFpEF). The Alleviant System is a novel transcatheter device for the creation of a therapeutic interatrial shunt without a permanent cardiac implant. Results were presented at the American College of Cardiology Scientific Session (ACC.21) and at the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR 2021) by Colin Barker, MD, &hellip; Continue reading &quot;Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-17T13:39:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences\",\"datePublished\":\"2021-05-17T13:39:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/\"},\"wordCount\":587,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/\",\"name\":\"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-05-17T13:39:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences - Market Newsdesk","og_description":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences Minimally-invasive, implant-free technology for heart failure patients studied at 1 and 3 months AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Alleviant Medical Inc., a privately-held medical device company, today announced one-month and three-month follow up data from the first in human clinical study (ALLEVIATE-HF-1) of its technology for the treatment of heart failure with preserved ejection fraction (HFpEF). The Alleviant System is a novel transcatheter device for the creation of a therapeutic interatrial shunt without a permanent cardiac implant. Results were presented at the American College of Cardiology Scientific Session (ACC.21) and at the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR 2021) by Colin Barker, MD, &hellip; Continue reading \"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-17T13:39:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences","datePublished":"2021-05-17T13:39:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/"},"wordCount":587,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/","name":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-05-17T13:39:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210517005480r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alleviant-medical-announces-presentation-of-clinical-data-at-american-college-of-cardiology-and-europcr-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/494419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=494419"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/494419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=494419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=494419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=494419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}